Trials / Recruiting
RecruitingNCT05963126
Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients
Modified Urine Fetuin A as a Predictor of Deterioration of Renal Function in Patients With Resistant and Non-resistant Hypertension
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University Hospital Ostrava · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Commonly used parameters (creatinine, estimated glomerular filtration rate, and urine albumin/creatinine ratio) for prediction of decline of renal function are sensitive for advanced kidney impairment. Modified human urine Fetuin A (urine Fetuin A) with specific modification in urine (Fetuin A) can earlier predict the progression of kidney disease in patients with diabetes. Studies evaluating urine Fetuin A in hypertonic patients are still lacking.
Detailed description
Arterial hypertension and diabetes are the most common cause of chronic kidney disease. Commonly used parameters for the evaluation of renal function (plasma creatinine, estimated glomerular filtration rate, and urine albumin/creatinine ratio) are sensitive to advanced kidney disease. Parameters predicting early kidney impairment are still lacking. Modified human urine Fetuin A with specific modification in urine (urine Fetuin A) presents a new biomarker that seems to be promising in the early prediction of kidney disease in patients with diabetes without microalbuminuria. Studies evaluating urine Fetuin A in hypertonic patients are still lacking.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention. | No intervention. |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
- First posted
- 2023-07-27
- Last updated
- 2023-07-27
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT05963126. Inclusion in this directory is not an endorsement.